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Accepted 2 October 2015; Published online 16 October 2015AbstractObjectives: The objectives of this article are to (1) comprehensively catalog outcomes measured in trials of childhood vaccination
communication interventions and (2) analyze patterns and trends in outcome selection. To achieve these objectives, we developed a Trial
Outcomes Map for vaccination communication.
Study design: We searched the Cochrane Central Register of Controlled Trials for trials of childhood vaccination communication in-
terventions, extracting verbatim all outcome information from included trials. Through thematic grouping, we categorized outcomes based
on conceptual similarities, forming a Trial Outcomes Map.
Results: We identified 112 relevant trials containing 209 outcomes. Thematic analysis revealed three overarching Outcome Categories:
consumer-, vaccination-, and health system-related outcomes. These categories contain 21 Outcome Types (eg, ‘‘knowledge,’’ ‘‘cost’’),
measured using 66 different Outcome Variables. Vaccination outcomes were measured most frequently and health system-related outcomes
least frequently. Consumer outcomes are increasingly measured in more recent trials.
Conclusion: The number of measures used for the same outcomes complicates data synthesis and interpretation. Despite recent trends
toward including consumer outcomes, intermediate outcome measurement is lacking, hampering understanding of how and why vaccina-
tion communication interventions do or do not work. This Map may improve outcome consistency in future trials and will contribute to a
forthcoming core outcome set.  2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Effective communication with parents and commu-
nities is critical to addressing vaccine hesitancy and
improving global childhood vaccination uptake [1e4].
As the Global Polio Eradication Initiative states,
‘‘communications [sic] is the poor cousin of vaccine
delivery, undeservedly receiving far less focus . But
communications is everybody’s business’’ [5]. Aess article under the CC BY-NC-ND license (http://creativecommons.org/
inical Epidemiology 72 (2016) 33e44What is new?
Key findings
 Trials of childhood vaccination communication in-
terventions measure three categories of outcomes:
vaccination-, consumer-, and health system-
related outcomes
 Most trials focus on vaccination-related outcomes,
but there is wide variation in how these key out-
comes are measured
 Potentially important consumer-related and health
system-related outcomes are less frequently
measured
What this adds to what was known?
 This Map is a novel extension of existing outcome
mapping methodology and presents the first
comprehensive mapping and analysis of outcomes
associated with vaccine-related communication
trials
What is the implication and what should change
now?
 This Map may improve consistency in outcome se-
lection and reporting for trials and will be used in
future consultation with stakeholders to develop a
core outcome set
communication intervention is defined as a purposeful,
planned, and formalized strategy associated with a diverse
range of aims, including to inform, educate, remind, sup-
port, or change behavior [6]. Communication for vaccina-
tion can take many forms and can operate at individual,
interpersonal, organizational, community, and public health
sector levels [4,6,7]. Communication interventions may
target parents, health professionals, whole communities,
or health organizationsdor multiple different groups at
once. Measuring the effects of this diversity of communica-
tion interventions therefore requires clarity and consistency
in the outcomes used for such measurement. Additionally,
as interest grows in strategies that involve and engage with
communities [8], it is increasingly necessary to determine
which outcomes are relevant and appropriate to different
stakeholders (eg, parents, community leaders, vaccination
program managers).
Communication about childhood vaccination is increas-
ingly recognized as an area which can and should be evi-
dence informed [7,9e11]. However, little research has
focused on determining what outcomes should be measured
in trials of vaccination communication interventions, and
there are a number of challenges to developing the evidence
base in this area. First, trials in this area often use different
34 J. Kaufman et al. / Journal of Cldefinitions for key outcomes, such as vaccination status or
uptake, as well as different ways to measure them (eg, by
vaccination cards and/or by mother’s report), making it
difficult to interpret study findings or compare results
across studies [12].
Second, interventions that aim to increase vaccine
coverage may be complex and include several components,
of which communication may only be one (eg, [13e15]).
Measuring a single end-point outcomedsuch as vaccina-
tion statusdcan make it difficult to evaluate the effective-
ness of the individual communication components, as
compared to other parts of the intervention. These other
components, such as monetary incentives or improved ac-
cess to vaccine providers, may mask or boost the effects
of the communication components. Without a clear under-
standing of which elements are effective and which are not,
resources may be expended on multifaceted interventions
in which only some components are effective [16].
Finally, intermediate outcomesdsuch as attitudes and
beliefs or intention to vaccinatedshould be measured in
addition to typical end-point outcomes, such as change in
vaccination rates. Intermediate outcomes help determine
and test the pathways through which an intervention may
work [16e18]. Understanding causal pathways is espe-
cially important when assessing the effects of complex in-
terventions [19,20], but many trials and reviews of complex
interventions measure only end-point outcomes [11]. For
example, a recent Cochrane systematic review found a lack
of meaningful intermediate outcome measurement in trials
of face-to-face communication about childhood vaccination
[9], and an overview of reviews found that intermediate
outcomes were seldom assessed for communication around
medicines use and vaccination [11].
Intermediate outcomes are also important because some
vaccination communication interventions may lead to a bet-
ter understanding among parents or caregivers of the need
for vaccination, and more informed decision making, but
they may still choose not to or may be unable to vaccinate
(eg, because of barriers to access). Measuring the finaldbut
not intermediatedoutcomes would erroneously suggest
that these communication interventions are not worth
exploring. Additionally, consumer-related outcomes are
not always intermediate outcomes. In some trials, they
could be the end-point outcomes, as creating informed ser-
vice users may itself be the goal of the intervention [21].1.1. Core outcomes
The development and use of evidence-based core
outcome sets (COSs) is one way to bring consistency to
outcome measurement and reporting in a given field or
topic area. COSs are agreed-on standardized groups of out-
comes for particular health conditions or topics [22].
Although additional relevant outcomes may be measured,
COSs are intended to establish a minimum standard set
of outcomes to be measured in all effectiveness trials on
35J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44a particular topic. COSs can help increase the relevancy of
research evidence to decision makers, improve evidence
synthesis across studies, or help reduce selective outcome
reportingda notable problem in trials [23e26].
At present, two leading research collaborations in COS
research are The Outcome Measures in Rheumatology
(OMERACT) and the Core Outcomes in Effectiveness Tri-
als (COMET) (www.comet-initiative.org) initiatives.
OMERACT has been engaged in developing COSs for
rheumatology since 1992 [27]. COMET maintains a
comprehensive database of projects and publications
related to COS development and methodology across a
range of topics [22,28]. OMERACT’s approach distin-
guishes between what to measuredwhich they term
‘‘domains’’dand how to measured‘‘outcome measure-
ments,’’ which covers the instruments used to assess each
domain. Reflecting this distinction, an OMERACT ‘‘core
outcome set’’ is actually a ‘‘core outcome measurement
set.’’ COMET’s language is more general, with the word
‘‘outcome’’ referring to the concept to be measured and
‘‘instrument’’ referring to the way it is measured. In this
article, we use the more general COMET language, as we
describe the identification of the range of concepts
measured as outcomes in trials of vaccination communica-
tion interventions. In later stages, as our conceptual work
becomes more focused, we plan to develop what OMER-
ACT terms ‘‘core areas’’ and ‘‘domains,’’ and we do not
want to confuse the outputs of these two project stages.
Although interest in COSs is growing, the COMET data-
base indicates that most COSs are related to clinical inter-
ventions; very few address interventions directed at
consumers such as communication. We are therefore under-
taking research on vaccination communication COS meth-
odology and development as part of the ‘‘Communicate to
Vaccinate (COMMVAC 2)’’ project (www.commvac.com),
an international project addressing evidence-based commu-
nication about childhood vaccination in low- and middle-
income countries. The ultimate output of this multistage
project will be a preliminary COS for a vaccination
communication intervention assessed as a priority by
stakeholders.
There is no single methodology for developing a COS,
although researchers from COMET and OMERACT have
published some overarching guidance for the process
[28,29]. Broadly speaking, both groups indicate that the
process should include setting the scope of the COS, iden-
tifying existing outcomes through literature review, consul-
ting with a range of stakeholders and engaging in a
consensus process to identify what should be measured
[22].
Much of the published literature on COSs focuses on
this consensus process and the production of the final
COS. There are fewer descriptions of the earlier stages of
development, most notably the linking step between the
literature review and the consultation and consensus pro-
cesses. Communication for vaccination is still an emergentfield of research: the COMMVAC interventions taxonomy
was the first to comprehensively define the range of vacci-
nation communication interventions [4]. To our knowledge,
there has not yet been an effort to similarly illuminate the
range of related outcomes that have been measured. There-
fore, we have expanded this linking step between literature
review and stakeholder consultation by developing a Trial
Outcomes Map. The Map is a significantly enhanced liter-
ature review output, forming the basis for consultations
with stakeholders in subsequent stages of this project. It
is also the first step toward organizing this complex array
of outcomes into core areas and domainsda process which
has been described in a small number of articles predomi-
nantly focusing on clinical interventions for health
conditions [29e32] but which has not yet been undertaken
for outcomes of consumer-oriented preventive health
interventions.
1.2. Objectives
The objectives of this article are to (1) comprehensively
catalog which outcomes have been measured in trials of
childhood vaccination communication interventions, in
the form of a Map and (2) analyze patterns and trends in
outcome selection across studies. In this article, we
describe the methods for creating this Trial Outcomes
Map, report the results, and reflect on a number of impor-
tant trends in outcome reporting identified during this
process.2. Methods
In Fig. 1, we outline the steps of the COMMVAC COS
development project. In this article, we will address the first
three steps examining ‘‘What has been measured?’’
2.1. Literature search
We searched the Cochrane Central Register of
Controlled Trials (CENTRAL) for trials of communication
interventions related to childhood vaccination. For this
search, we used a strategy developed for an earlier phase
of the COMMVAC project in which we developed a taxon-
omy of vaccination communication interventions [4,7]. The
search strategy incorporated communication terms derived
from the Cochrane Consumers and Communication Review
Group (CCCRG) scope [34] and vaccination terms based
on a relevant Cochrane review [35] (Appendix A at www.
jclinepi.com). There were no date limitations. We
compared the search output with the output from the earlier
phase to ensure that we captured all results.
The rationale for searching only CENTRAL was that we
were specifically interested in outcomesmeasured in trials of
vaccination-related communication interventions, and CEN-
TRAL is the largest global database of trials. Our experience
from undertaking two Cochrane systematic reviews on this
Fig. 1. Methods for developing the Communicate to Vaccinate (COMMVAC) Core Outcome Set. 1Cochrane Consumers and Communication Review
Group outcomes taxonomy [33]. 2COMMVAC 1 interventions taxonomy [4].
36 J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44topic suggested that the considerable resources needed to
screen other databases did not greatly increase the yield of
relevant trials [9,10]. Furthermore, in future steps (outlined
in Fig. 1) we will supplement our Trial Outcomes Map with
outcomes raised by stakeholders and from other types of
studies based on gaps identified through comparative
analysis.
We included trials (randomized, quasi randomized, or
cluster controlled) if they
(1) evaluated a communication intervention [7].
(2) focused primarily on a vaccination population of chil-
dren up to 6 years of age.
(3) addressed routine childhood vaccines only [36].
(4) reported communication which was addressed to
caregivers or community members and was related
to childhood vaccination. Communication interven-
tions directed to health professionals were not
included unless they specifically impacted the
encounter between the provider and parents. This
focus reflects the scope of the COMMVAC project
[4,7].
(5) were written in English.2.2. Extracting data on measured outcomes
For each outcome mentioned in an included trial, we ex-
tracted into a spreadsheet all information defining the
outcome, such as type (eg, vaccination status), outcome
variables (eg, up to date for all scheduled vaccines), age
of the subjects (eg, up to age 2), and any other related de-
tails. We used the exact words of the trial authors. We did
not extract data related to the timing and scale or tool usedto measure the outcomes, as examination of how specific
Outcome Variables were measured was not the subject of
the research.2.3. Thematic grouping
Two researchers (J.K. and S.H.) reviewed the extracted
data. One author (J.K.) coded the individual outcomes ac-
cording to what these measured, using the language of
the trialists. These codes were discussed and confirmed
with S.H. This first round of codes became the most spe-
cific level of the taxonomy. We retained a relatively large
number of different groups, rather than aggregating the in-
formation and potentially losing important details.
We then repeated the inductive coding and grouping pro-
cess to build to progressively broader Outcome Categories,
informed by our experience and perspective on evaluating
communication interventions [4,6]. We constantly
compared the outcome information with the emerging co-
des until all outcomes were coded, establishing groups of
thematically similar outcomes [37].
The process at each level was iterative and the final Map
structure and organization was based on several rounds of
discussion within the research team, which includes experts
in vaccination and communication research with experience
in taxonomy development [4,6,16].
The groupings in this Trial Outcomes Map enabled us to
analyze patterns in the frequency of end point and interme-
diate outcome measurement across trials. Following the
example of Sinha et al. [31], we also analyzed trends in
outcome measurement over time, although this analysis
was limited by sample size. To identify any clear or crude
changes, we divided the trials into two groups by median
37J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44year of publication (2000) and counted the number of times
outcomes from each overarching Category were measured
in these two groups.
3. Results
In the following sections, we report on steps 1 and 2 of
the Trial Outcomes Map development process (Fig. 1),
describe the Trial Outcomes Map produced, and identify
key trends related to vaccination communication outcomes.
3.1. Included trials
We ran the search in November 2013 and found 889 tri-
als. We compared these results with those returned in the
earlier search (conducted in 2011 and screened by two re-
searchers) and added nine additional trials that were not
captured by the most recent search (most likely due to
changes in indexing). This left us with 898 trials, from
which we removed eight duplicates. One researcher (J.K.)Fig. 2. Classification ofscreened these 890 results by title, abstract, and full text
where necessary. A total of 112 trials met our inclusion
criteria (see Fig. 2).
The included trials evaluated communication interven-
tions that intended to inform or educate, remind or recall,
teach skills, provide support, facilitate decision making,
enable communication, or enhance community ownership
related to childhood vaccination [4]. The complete refer-
ence list of included trials can be found in Appendix B at
www.jclinepi.com.3.2. The outcomes
Of the 112 trials, 87 measured fewer than three out-
comes; 21 trials measured three to five outcomes; and four
trials measured more than five outcomes. In total, we ex-
tracted information on 209 separate outcomes, cataloging
what has been measured to develop the Trial Outcomes
Map. We present the Map from the largest to smallest levelarticles retrieved.
38 J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44of conceptual specificity for clarity, but as explained in the
Section 2, it was developed in the reverse direction.
The three levels of the Map from the broadest to smallest
are Outcome Categories (of which there are three),
Outcome Types (21), and Outcome Variables (66) (see
Table 1) [38e40].
The three overarching Outcome Categories are as
follows:
 Consumer-related outcomes (ie, outcomes relevant to
the thoughts, feelings, experiences, and decision mak-
ing of parents or community members dealing with
childhood vaccination),
 Vaccination-related outcomes (ie, outcomes assessing
changes in vaccination status or behavior), and
 Health system-related outcomes (ie, outcomes rele-
vant to systems-level issues).
Outcome Types are the concepts being measured. These
are organized alphabetically, rather than by frequency of
measurement or other criteria, so as not to suggest a hierar-
chy of importance.
Outcome Variables refer to the ways in which different
trials define and measure outcomes. They are not the instru-
ments or scales used to collect data, which would be more
specific still. For example, the Outcome Type ‘‘appoint-
ment attendance’’ was assessed with nine separate Vari-
ables, including the following: number of appointments
attended; kept appointment rate; and canceled; or no-
show appointments.
Some Outcome Types contain similar Variables, but with
nuanced differences. For example, ‘‘receipt of vaccine’’ in-
cludes measures of whether any kind of vaccination was
received by children, although ‘‘vaccination status’’ refers
to the extent to which the child received the vaccinations
that they should have (eg, by a particular time).3.3. Outcome patterns and trends
Grouping the Map into Outcome Categories, Types, and
Variables helped us identify patterns and trends in outcome
selection and measurement. Fig. 3 shows the number of
different Variables for each Outcome Type, listed in order
of most to fewest Variables.3.3.1. Variation across outcomes used to assess
vaccination
As might be reasonably expected, the most commonly
measured Outcome Types were end-point vaccination out-
comes. Of the 112 trials identified, 89 (80%) measured at
least one vaccination-related outcome. We identified six
vaccination-related Outcome Types: ‘‘appointment atten-
dance,’’ ‘‘on time vaccination,’’ ‘‘probability of reaching
one year without each immunisation,’’ ‘‘receipt of
vaccine,’’ ‘‘time to vaccination,’’ and ‘‘vaccination status.’’
These Outcome Types evaluate different aspects ofvaccination that may be impacted by a communication
intervention.
At the level of Outcome Variables (ie, the level at which
they are measured), we found a substantial degree of varia-
tion. The six Outcome Types are represented by 28 different
Outcome Variables. This is most concerning in the Types
‘‘receipt of vaccine’’ (measured using nine Variables) and
‘‘vaccination status’’ (five Variables). The fact that trialists
do not appear to be drawing on standard measures for these
end points may create a range of problems, not least of
which is difficulty comparing the effects of interventions.
3.3.2. Consumer- and health system-related outcomes
Consumer-related and health system-related outcomes
are also important when evaluating the effectiveness of
vaccination communication interventions, but this Map
again shows the lack of consensus around which Outcome
Types and Variables are and should be assessed in trials.
Consumer-related outcomes were measured by 31 trials,
or 28% of the total mapped trials. ‘‘Knowledge’’ and ‘‘atti-
tudes or beliefs’’ were the two most commonly measured
consumer-related Outcome Types, assessed by 16 and 5 tri-
als respectively. ‘‘Intervention evaluation,’’ which ad-
dresses consumers’ views, impressions, and assessments
of the communication intervention itself, was measured
by five trials. As with vaccination-related Outcome Types
such as ‘‘receipt of vaccine,’’ key consumer-related out-
comes such as ‘‘knowledge’’ were measured by a large
number of different Outcome Variables (nine). The varia-
tion in the consumer-related outcomes assessed by trials
is evidenced by the fact that 31 trials measured 14 different
Outcome Types using 33 different Outcome Variables.
Health system-related outcomes included ‘‘missed oppor-
tunities for vaccination’’ and ‘‘cost or cost-effectiveness of
the intervention.’’ These outcomes were measured by 20%
of the trials (22 trials).
3.3.3. Trends over time
The analysis indicates a number of trends in outcome
measurement over time. We divided the trials into two
groups by median year of publication (2000) and compared
across these groups the number of times outcomes from
each of the three broad Outcome Categories were measured.
Fifty-four trials measuring 92 outcomes were published
before 2000, and 58 trials measuring 117 outcomes were
published since 2000. The most notable trend is the increase
in consumer-related outcome measurement. Of the out-
comes measured by the pre-2000 trials, 15% were consumer
related (14 separate outcomes). This increased to 34% of all
outcomes measured after 2000 (40 outcomes) (see Fig. 4).
Although more consumer-related outcomes were measured
in recent years, this increase is not distributed evenly across
all trials: of the 40 consumer-related outcomes measured
since 2000, 23 were measured in only four trials [41e44].
The frequency of vaccination-related outcome measurement
has remained broadly stable over time (68 vaccination-
Table 1. COMMVAC Childhood Vaccination Communication Trial Outcomes Map
Outcome Categories Outcome Types (Na) Outcome Variables
Consumer-related outcomes Anxiety (2)  About vaccine-preventable diseases
 As a result of the intervention
Attitudes and beliefs (8)  About vaccination
 About specific vaccine(s)
 About the intervention
Decision making (2)  Decision anxiety
 Decision satisfaction
 Decisional conflict
Evaluation of the communication intervention (5)  Acceptance of intervention
 Readability and comprehension
 Opinion on effectiveness
 Information material preference
 Information timing preference
 Response to information
Information retention over time (1)  Long-term memories of or actions resulting from
intervention
Intention to vaccinate (4)  Intended choice
 Likelihood of immunizing on time
Knowledge (16)  Change in knowledge about vaccination and other
child health issues
 About particular disease(s) and related vaccines
 About schedule
 About general child health issues including
vaccination
 About contraindications to vaccination
 About side effects of immunization
 About risks and benefits of immunization
 About local vaccine services
 Physician knowledge about vaccination
Patient-centeredness of care (2)  Satisfaction and experiences with seeking care
Perceived behavioral control (1)  Perceived ease or difficulty of keeping a vaccination
appointment
Perceived outcome efficacy (1)  Perceived benefits and costs of performing the
recommended health behavior
Reason for undervaccination (1)  Missed opportunity or missed visit
Risk perception (2)  Self-reported perception risk of immunization and of
disease
Subjective norm (1)  Self-reported assessment of whether significant
others think a person should or should not engage in a
behavior
Use of the communication intervention (1)  Number of hits to Web site and calls to helpline
Vaccination-related outcomes Appointment attendance (18)  Number of appointments attended
 Number of appointments scheduled
 Timeliness of well-child visits
 Attendance at at least one visit
 Attendance at four or more visits in 1 year
 Number of children attending health center once in
particular time frame
 Kept appointment rate
 Canceled or no-show appointments
 Rate of participation in screening services
On-time vaccination (9)  Receipt of vaccine(s) within recommended time
frame for each vaccine
Receipt of vaccine (46)  Receipt of one or more vaccines
 Immunization (not further clarified)
 Number of immunizations received per child
 Number of children immunized
 Vaccination dropout rate
 Proportion of eligible children who received vaccine
 Compliance with health care maintenance procedures
(including vaccination)
 Number of children brought up to date
 Number of vaccines per study group
(Continued )
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Table 1. Continued
Outcome Categories Outcome Types (Na) Outcome Variables
Time to vaccination (4)  Median number of days from enrollment to
vaccination
 Days without immunization coverage in first
15 months
 Number of days spent not up to date
 Probability of reaching 1 year of age without each
immunization
Vaccination status (41)  Age-appropriate vaccination (all required vaccines
due by any age)
 Up to date with all required vaccines at 24 months
 Up to date for particular vaccine
 Fully, partially, or unimmunized
 Underimmunized
Health system-related outcomes Cost and cost-effectiveness of intervention (10)  Monetary
 Time required to deliver the communication
intervention
Missed opportunities (12)  Rate of missed opportunities
 Rate of captured opportunities
 Rate of vaccination orders for inpatients (missed op-
portunities in hospital)
Abbreviation: COMMVAC, Communicate to Vaccinate.
a Number of studies measuring this Outcome Type.
40 J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44related outcomes measured in trials published before 2000,
and 65 measured in post-2000 trials).4. Discussion
This Trial Outcomes Map comprehensively catalogs the
outcomes that have been measured in trials of childhood
vaccination communication interventions, categorizing them
into three overarching Outcome Categories: vaccination-
related, consumer-related, and health system-related out-
comes. Analysis of the patterns shows that most trials focusFig. 3. Number of Outcome Varon vaccination-related outcomes, but that there is wide vari-
ation in how these key outcomes are measured. Potentially
important consumer-related and health system-related out-
comes are not widely measured, although a basic analysis
of trends over time does suggest some increased awareness
of consumer-related outcomes.
4.1. Too much variation in the way in which key
vaccination outcomes are measured?
The trial literature defined key Outcome Types using
many different Outcome Variables, meaning there isiables per Outcome Type.
74%
11%
15%
Pre-2000
VACCINATION-
RELATED
HEALTH 
SYSTEM-
RELATED
CONSUMER-
RELATED
VACCINATION
HEALTH 
SYSTEM
CONSUMER
56%
10%
34%
2000 and later
VACCINATION-
RELATED
HEALTH 
SYSTEM-
RELATED
CONSUMER-
RELATED
VACCINATION-RELATED
CONSUMER-RELATED
HEALTH SYSTEM-
RELATED
HEALTH SYSTEM
CONSUMER
VACCINATION
Total n = 117 outcomes
VACCINATION-RELATED 
CONSUMER RELATED 
HEALTH SYSTEM-
RELATED 
Total n = 92 outcomes
Fig. 4. Percentage of outcomes from each Outcome Category by study publication year.
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ment. The most significant concern from the perspective
of building an evidence base is that this kind of variation
makes it difficult or impossible to compare key outcomes,
for example, vaccination status, or to combine them in a
useful synthesis.
It is unclear if the proliferation of vaccination-related
Outcome Types and Variables represents a reasonable
response and adaptation to the varying contexts of
different trials or if it indicates a problemdfor example,
trialists legitimately diverging from past research because
of its limitations or trials conceived in isolation from pre-
vious research [45,46]. Some variation may be inevitable
due to practical limitations in the way that data are
defined, recorded, or made available to researchers [12].
For example, immunization registries or records are not
equally available or may not contain the same information
in all settings.
However, trialists often have a choice of which out-
comes to measure, and their selections should bedbut
are not alwaysdbased on the available evidence. For
instance, research evidence indicates that age-appropriate
immunization Outcome Variables that address the timeli-
ness of vaccination (eg, receipt of a specific vaccine
within the recommended time frame for that vaccine’s de-
livery) are more accurate and precise than measures of
up-to-date vaccination at a particular time point, such as
24 months of age [47e50]. Stakeholder consensus in the
form of a COS could help reduce unnecessary outcome
variation, help decide which outcomes are more important
for trials of communication interventions as compared to
other types of vaccination interventions, and ensure
that recommended outcomes are based on appropriate
evidence.
In the next steps of the COS research process, we will
build on the Outcomes Map by consulting with parents,
health providers, researchers, and policy makers to identify
additional outcomes and determine which outcomes are
most relevant and important to these stakeholders.Additional future research could investigate which outcome
measurement tools are used at the Variable level and
whether these are logical adaptations of existing tools or
wasteful development of new tools.4.2. The narrow scope of outcomes assessed in trials of
childhood vaccination communication
interventionsdwhat’s missing?
This Map outlines what has been measured in trials to
date, but how can we address the gapsdoutcomes that
should be measured but are currently measured infre-
quently or not at all? Vaccination communication typically
comprises complex interventions and the causal pathways
between delivery of the communication intervention itself
and changes in end points such as vaccination behavior
are not well understood. To enhance our understanding of
the mechanisms by which vaccination communication in-
terventions function, researchers need to measure appro-
priate intermediate outcomes as well as end points.
The trend in the more recently published trials toward
measuring consumer-related outcomes is promising and
may reflect an increased focus on trying to understand
intervention processes [17,51,52] or overall trends in public
health toward adoption of interventions that aim to improve
consumer experiences, engagement, and participation in
health [6,53e56]. However, qualitative literature and trials
from other related fields indicate that the outcomes derived
from trials and included in this Map are not yet sufficient or
complete. For instance, a number of important decision
making outcomes such as value clarity and self-efficacy,
which are highly relevant to the aim of improving informed
choice about vaccination, were not measured in any vacci-
nation communication trials and therefore do not appear in
the Map [57,58].
The Map also shows that health system-related out-
comes are measured relatively infrequently in communica-
tion intervention trials. This may be due in part to the scope
of the included trials, which reflect the scope of the
42 J. Kaufman et al. / Journal of Clinical Epidemiology 72 (2016) 33e44COMMVAC project in their focus on communication inter-
ventions directed to or directly impacting parents or com-
munities [4]. However, some key health system-related
outcomes such as cost or cost-effectiveness are relevant
for any intervention trial, including those oriented toward
consumers. The importance of evidence on costs to deci-
sion makers has been highlighted by key organizations such
as The Cochrane Collaboration and the US Agency for
Healthcare Research and Quality [59,60].
To identify additional potential outcomes, in the next
steps of this project, we will conduct focus groups with
consumers and other stakeholders and compare the Map
with other sources of relevant outcomes, such as the related
communication outcomes taxonomy of the CCCRG [33].
COMMVAC researchers are also conducting a qualitative
evidence synthesis focusing on parents’ and carers’ views
and experiences of routine early childhood vaccination
communication. This synthesis may help clarify which out-
comes are most relevant and important to parents and carers
and also the pathways between intervention delivery and
important end points.4.3. Strengths and limitations
This Map is the first comprehensive methodological
scoping of outcomes associated with interventions for
vaccine-related communication. It encompasses outcomes
related to consumers’ views and experiences, vaccination
status and behavior, and health systems. Our methodolog-
ical approach adapts and extends the relatively limited de-
scriptions of the processes for outcomes mapping in
clinical areas [29e32] and sheds light on the complexities
associated with measuring the effects of vaccination
communication interventions. This Map also furthers the
field of COS development research by making explicit
the methodological link between literature review and
stakeholder consultation.
Because we conducted our search only in CENTRAL,
which indexes primarily randomized controlled trials
(RCTs), we may have missed some relevant studies that
used other research designs such as non-RCTs, controlled
before and after, interrupted time series, or qualitative
studies. Different study designs may have included a
different range of outcomes. However, for this Map, we
were primarily interested in the outcomes reported in RCTs
because these provide the most reliable evidence on the
effectiveness of health interventions and are the basis of
systematic reviews of intervention effectiveness. Therefore,
limitations or inconsistencies in outcome reporting at the
RCT level have repercussions for policy makers, guideline
and guidance developers, health providers, and other deci-
sion makers who use systematic review evidence.
The future comparative analysis steps of the process will
cover other study designs and literature including material
not published in English.5. Conclusion
With the growth in the evaluation and systematic review
of health interventions [61], there has been new interest in
the development of COSs, simultaneously influenced by the
interest in specifying outcomes of most importance to
different stakeholders [28]. Most COS-related studies focus
on clinical conditions [22]. There are a small number of
projects, most also in the early stages of development, ad-
dressing interventions directed at consumers or health sys-
tems (eg, interventions for informed consent [62]), but this
project is among the first to develop a COS for a consumer-
oriented preventive health intervention such as vaccination
communication.
Communication around childhood vaccination is a
developing area with many innovative and often complex
interventions that are not yet rigorously evaluated or their
mechanisms of effect well understood [4]. We have created
this Trial Outcomes Map to bring clarity and organization
to an area that is complex, and to highlight patterns and po-
tential problems that were previously unexplored. The Map
is a base platform that illustrates the current state of
outcome measurement in trials; from this platform, we
can explore additional potential outcomes through stake-
holder consultations and comparative analyses.Acknowledgments
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